HIF1A and type 2 diabetes mellitus: Intriguingly, the treatment of diabetic mice with the HIF-1α inhibitor PX-478 improves insulin secretion and glucose tolerance [38], suggesting that the inhibition of HIF-1α might be a potential treatment for type 2 diabetes (Figure 2D).